Variant report
Variant | nsv972209 |
---|---|
Chromosome Location | chr8:39189305-39220648 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:6)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
(count:6 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-ADAM32-1 | chr8:39203380-39203563 | NONHSAT147629 |
2 | lnc-ADAM32-1 | chr8:39192919-39193012 | NONHSAT126157 |
3 | lnc-ADAM32-1 | chr8:39192919-39193008 | NONHSAT126156 |
4 | lnc-ADAM32-1 | chr8:39203380-39203563 | NONHSAT147628 |
5 | lnc-ADAM32-1 | chr8:39203380-39203563 | NONHSAT126155 |
6 | lnc-ADAM32-1 | chr8:39203380-39203563 | NONHSAT126148 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs368935796 | chr8:39189316-39189317 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs201683103 | chr8:39189323-39189324 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs111536025 | chr8:39189350-39189351 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs370588232 | chr8:39189374-39189375 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs552910138 | chr8:39189378-39189379 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs77209597 | chr8:39189435-39189436 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs114205325 | chr8:39189440-39189441 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs4076224 | chr8:39189481-39189482 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs139990963 | chr8:39189623-39189624 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs192873133 | chr8:39189627-39189628 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs563977982 | chr8:39189658-39189659 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs184305619 | chr8:39189660-39189661 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs540188217 | chr8:39189736-39189737 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs371347898 | chr8:39189780-39189781 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs560526060 | chr8:39189795-39189796 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs529238521 | chr8:39189800-39189801 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs375228655 | chr8:39189813-39189814 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs367869032 | chr8:39189814-39189815 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs531853684 | chr8:39189828-39189829 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs187497164 | chr8:39189840-39189841 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs192328025 | chr8:39189863-39189864 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs538380842 | chr8:39189870-39189871 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs534491056 | chr8:39189903-39189904 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs554134699 | chr8:39189909-39189910 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs4330659 | chr8:39189956-39189957 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs568472838 | chr8:39190205-39190206 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs374545863 | chr8:39190221-39190222 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs4236760 | chr8:39190232-39190233 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs557510417 | chr8:39190261-39190262 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs577798721 | chr8:39190292-39190293 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs540440249 | chr8:39190303-39190304 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs560161036 | chr8:39190337-39190338 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs529191939 | chr8:39190431-39190432 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs386724629 | chr8:39190461-39190462 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs192185996 | chr8:39190514-39190515 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs13266652 | chr8:39190515-39190516 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs531816813 | chr8:39190533-39190534 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs527781577 | chr8:39190609-39190610 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs551937799 | chr8:39190637-39190638 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs10107719 | chr8:39190667-39190668 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs184564440 | chr8:39190672-39190673 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs547970290 | chr8:39190740-39190741 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs111544932 | chr8:39190791-39190792 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs189280000 | chr8:39190821-39190822 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs369432680 | chr8:39190890-39190891 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs371814356 | chr8:39190898-39190899 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs570494767 | chr8:39191054-39191055 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs554938217 | chr8:39191263-39191264 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs568543133 | chr8:39191292-39191293 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs537533665 | chr8:39191310-39191311 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Prostate cancer | 16573809 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Prostate cancer | 21965145 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Lung cancer | 18438408 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Immune disease | 21572526 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Kallmann Syndrome 2 | 22470819 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Developmental delay | 21373258 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 17603634 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Bladder cancer | 19088036 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Breast cancer | 17001308 | CNVD |
Breast cancer | 17157792 | CNVD |
Cancer | 17001308 | CNVD |
Cancer | 18840272 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Chordoma | 18071362 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 16608533 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 21785460 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 16620391 | CNVD |
Rhabdomyosarcoma | 16790082 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Prader-willi syndrome | 20588305 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Cancer | 20164920 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 20932292 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:39188000-39189400 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
2 | chr8:39188000-39189400 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
3 | chr8:39189200-39189800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
4 | chr8:39189400-39189800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
5 | chr8:39189400-39189800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
6 | chr8:39189600-39190000 | Enhancers | Fetal Stomach | stomach |
7 | chr8:39190200-39191000 | Enhancers | Fetal Kidney | kidney |
8 | chr8:39190400-39191600 | Enhancers | Fetal Lung | lung |
9 | chr8:39191200-39191400 | Enhancers | Osteobl | bone |
10 | chr8:39191200-39191600 | Active TSS | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
11 | chr8:39210800-39211400 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
12 | chr8:39215000-39215400 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |